ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,536Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1269

$1.4M Total Retail Price of All Prescriptions

Rank: 5 out of 1269

406 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 20,342 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
WARFARIN SODIUM 1,978 1,978 1 12
NEXIUM 1,003 999 2 41
ATORVASTATIN CALCIUM 942 916 3 7
METOPROLOL SUCCINATE 565 564 4 13
FUROSEMIDE 528 523 5 5
LEVOTHYROXINE SODIUM 503 479 6 4
AMLODIPINE BESYLATE-BENAZEPRIL 499 495 7 81
AMLODIPINE BESYLATE 437 435 8 2
LIDODERM 410 410 9 56
VOLTAREN 330 327 10 162
DIGOXIN 308 308 11 62
CRESTOR 268 259 12 25
ISOSORBIDE MONONITRATE ER 255 255 13 63
ENALAPRIL MALEATE 252 252 14 79
CELEBREX 246 245 15 95
CLONIDINE HCL 241 241 16 51
METOPROLOL TARTRATE 241 241 16 6
LISINOPRIL 240 233 18 1
TAMSULOSIN HCL 231 231 19 31
BENICAR HCT 229 229 20 170
JANUVIA 228 228 21 74
ZOLPIDEM TARTRATE 226 226 22 19
MECLIZINE HCL 226 225 22 140
HYDROCHLOROTHIAZIDE 220 220 24 10
METFORMIN HCL 217 209 25 9
LIPITOR 203 196 26 91
PANTOPRAZOLE SODIUM 188 184 27 18
MICARDIS HCT 187 187 28 249
JANUMET 173 173 29 225
CREON 173 173 29 248
LIDOCAINE-PRILOCAINE 162 160 31 278
SIMVASTATIN 159 159 32 3
COLCRYS 158 157 33 150
DIOVAN 154 144 34 35
SYMBICORT 154 154 34 173
SPIRONOLACTONE 142 142 36 77
SPIRONOLACTONE-HCTZ 142 142 36 228
OMEPRAZOLE 133 133 38 8
PRAMIPEXOLE DIHYDROCHLORIDE 132 131 39 293
BYSTOLIC 130 130 40 126
CARVEDILOL 129 128 41 29
ALENDRONATE SODIUM 129 129 41 28
ESCITALOPRAM OXALATE 127 127 43 58
PLAVIX 124 124 44 47
ALLOPURINOL 122 120 45 49
CLOPIDOGREL 121 121 46 32
ZALEPLON 120 120 10 47 271
BENICAR 118 118 48 153
CARTIA XT 116 116 49 304
CILOSTAZOL 115 115 50 272
COUMADIN 115 115 50 237
RANITIDINE HCL 115 115 50 27
ACTOS 113 113 53 161
ADVAIR DISKUS 110 110 54 46
NITROSTAT 109 109 55 191
SINGULAIR 107 107 56 123
NASONEX 103 103 57 230
ATENOLOL 100 93 58 14
VYTORIN 99 99 59 168
AZITHROMYCIN 95 94 60 42
PROAIR HFA 92 91 61 61
ACTOPLUS MET 90 90 62 325
POLYETHYLENE GLYCOL 3350 88 87 63 50
NIFEDIPINE ER 85 85 64 65
DIOVAN HCT 81 81 65 76
LANSOPRAZOLE 77 75 66 120
CLOTRIMAZOLE-BETAMETHASONE 72 72 67 175
PRANDIN 71 71 68 266
PRAVASTATIN SODIUM 70 70 69 11
POTASSIUM CHLORIDE 67 67 70 26
TRAMADOL HCL 65 65 71 16
AVODART 65 65 71 298
SPIRIVA 62 62 73 64
SERTRALINE HCL 62 62 73 23
DEXILANT 61 61 75 200
RANEXA 60 60 76 357
GLIPIZIDE ER 59 59 77 102
LANTUS 57 57 78 39
DOXAZOSIN MESYLATE 57 57 78 117
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 44 80 33
DONEPEZIL HCL 55 55 81 22
IBUPROFEN 55 55 81 73
LYRICA 54 54 83 92
LEXAPRO 53 53 84 174
FLUTICASONE PROPIONATE 51 49 85 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.